ZLAB - Zai Lab gets FDA fast track status for lung cancer treatment
2025-05-19 09:09:28 ET
More on Zai Lab
- Zai Lab Limited (ZLAB) Q1 2025 Earnings Call Transcript
- Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth
- Zai Lab: Still Attractive Despite Higher Costs And Added Trade War Risks
- Zai Lab Q1 2025 Earnings Preview
- Zai Lab gets China's acceptance for label expansion of repotrectinib